Last quarter (Q3 2023), Vivos Therapeutics's total revenue was $3.30M, a decrease of -22.26% from the same quarter last year. In Q3, Vivos Therapeutics's net income was $-2.09M. See Vivos Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 12.91M	$ 16.02M	$ 16.89M	$ 13.07M	$ 11.39M	$ 3.79M
Cost of Revenue	$ 7.13M	$ 6.00M	$ 4.28M	$ 2.65M	$ 2.74M	$ 1.08M
Gross Profit	$ 8.75M	$ 10.02M	$ 12.60M	$ 10.41M	$ 8.66M	$ 2.71M
Operating Expense	$ 66.36M	$ 35.05M	$ 32.08M	$ 19.12M	$ 19.23M	$ 11.05M
Operating Income	$ -10.70M	$ -25.03M	$ -19.47M	$ -8.71M	$ -10.58M	$ -8.34M
Net Non Operating Interest Income Expense	$ 89.00K	$ 89.00K	$ 103.00K	$ -17.00K	$ -116.74K	$ -102.97K
Other Income Expense	$ -11.27M	$ -1.10M	$ 9.00K	$ -3.33M	$ -60.34K	-
Pretax Income	$ 2.25M	$ -23.84M	$ -20.29M	$ -12.06M	$ -10.75M	$ -8.44M
Tax Provision	$ 510.00K	$ 510.00K	$ 502.00K	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	$ 1.29M	$ 1.29M	-	-	-	-
Net Income Common Stockholders	$ -4.04M	$ -23.84M	$ -20.29M	$ -17.99M	$ -11.75M	$ -9.44M
Basic EPS	$ -2.19	$ -1.04	$ -0.96	$ -1.40	$ -0.67	$ -0.53
Diluted EPS	$ -3.04	$ -1.04	$ 0.00	$ -1.40	$ -0.67	$ -0.53
Basic Average Shares	$ 23.07B	$ 23.01B	$ 21.23B	$ 12.87M	$ 17.67M	$ 17.67M
Diluted Average Shares	$ 23.07B	$ 23.01B	$ 21.23B	$ 12.87M	$ 17.67M	$ 17.67M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 73.48M	$ 41.05M	$ 36.36M	$ 21.77M	$ 21.97M	$ 12.13M
Net Income From Continuing And Discontinued Operation	$ -15.23M	$ -23.84M	$ -20.29M	$ -12.06M	$ -10.75M	$ -8.44M
Normalized Income	$ -6.08M	-	-	$ -8.73M	$ -10.69M	$ -8.44M
Interest Expense	-	-	-	$ 96.00K	$ 137.88K	$ 102.97K
EBIT	$ 2.17M	$ -23.84M	$ -20.39M	$ -11.96M	$ -10.62M	$ -8.34M
EBITDA	$ 2.46M	$ -23.18M	$ -19.66M	$ -11.24M	$ -9.87M	$ -7.73M

Currency in USD

Vivos Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing